Payman Zamani, MD, MTR

Cardiology
Accepting new patients
Sees patients age 18 and up
Penn Heart and Vascular Center
Headshot of Payman Zamani, MD, MTR
Penn Medicine Provider

About me

  • Associate Professor of Medicine (Cardiovascular Medicine) at the Hospital of the University of Pennsylvania

My education and training

  • Residency: Massachusetts General Hospital/Brigham and Women’s Hospital
  • Fellowship: UC San Diego Medical Center
  • Fellowship: University of Pennsylvania Health System

Spoken languages

English
English

Reviews

Average Rating

66 reviews

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Anonymous
July 2026
kind, listens, smart, personable, caring
Anonymous
June 2026
very knowledgeable and thorough.
Anonymous
June 2026
i'd be happy to discuss or provide add'l details or context.
Anonymous
May 2026
i appreciate the way he answers questions completely, and fully and explains everything that i need to know about my condition and the medication that i take and the things that i can do to help myself feel better

Insurance accepted

Please contact the practice and/or the member services department of your insurance company for specific details before receiving services. Providers may participate in some, but not all, products offered by a health plan; providers may also accept plans at some practice locations but not others.

Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
Dr. Zamani is a Penn Medicine physician.

Qualifications and experience

Treatments and conditions

Research

Publications

Matsumoto C, Tavolinejad H, Nakano H, Bustamante M, Pourmussa B, Kim M, Mann DL, Javaheri A, Richards AM, Doughty R, Rietzschel E, van Empel V, Zamani P, Cohen JB, Cappola TP, Chirinos JA Proteomic Organ Age Gaps and Outcomes Across Heart Failure Phenotypes , American Heart Association Scientific Sessions, Chicago, IL: 2026


Matsumoto C, Tavolinejad H, Nakano H, Bustamante M, Pourmussa B, Kim M, Mann DL, Javaheri A, Richards AM, Doughty R, Rietzschel E, van Empel V, Zamani P, Cohen JB, Cappola TP, Chirinos JA Clinical Modifiers of Proteomic Organ Age Gap Associations in Heart Failure , American Heart Association Scientific Sessions, Chicago, IL: 2026


Kim M, Subramanian V, Tavolinejad H, Bustamante MS, Pourmussa B, Mann DL, Javaheri A, Richards AM, Doughty RN, Rietzschel E, van Empel V, Zamani P, Cappola TP, Tong D, Chung S, Pandey A, Chirinos JA. Clonal Hematopoiesis of Indeterminate Potential Proteomic Risk Score for Predicting Clinical Outcome in Patients with Heart failure with Preserved Ejection Fraction , Circulation: Heart Failure: 2026


Benyard B, Mathur A, Roy D, Swain A, Kohkhar SK, Soni ND, Wilson N, Haris M, Zamani P, Reddy R, Kumar D Dual-Breathing CrCEST: A Novel Imaging Method to Distinguish Oxygen Delivery and Utilization in Exercised Muscle , International Society for Magnetic Resonance in Medicine, Cape Town, South Africa: 2026


Rosenbaum M, Allison KC, Laughlin MR, Kelley SS, Nunez-Matos J, Rickles M, Chau L, Wu G, Zamani P, Whyte KJ, Leibel RL, Hayes MR. The Physiology Of the WEight Reduced State (POWERS) study: strategies for the analysis of biological specimens. , Int J Obes (Lond): 2026


Cohen JB, Hossain A, Chittams J, Zhao M, Afable J, Greenip A, Maynard H, Pourmussa B, Prenner SB, Selvaraj S, Townsend RR, Zamani P, Chirinos JA. Calcium Channel Blockade versus Beta-Blockade for Hypertension in HFpEF: A Randomized Crossover Trial , Hypertension, 83: 2026,e26801


Lin KY, Bucha A, McSweeney K, Wade KL, Karaj A, Tamaroff J, O’Malley S, Chung NM, Cilenti NA, Wanner J, Adzika GK, Mesaros C, Rojsajjakul T, Blair IA, Serai S, Farmer J, Bryant K, Harhay MO, Lu Y, Paridon SM, Weber DR, Seifert W, Putt ME, Zamani P, Baur JA, Lynch DR, McCormack SE. Individualized exercise and NAD+ precursor supplementation in Friedreich’s Ataxia: a randomized controlled trial. , Lancet: Neurology, 25: 2026,469


Vidula MK, Schurgers LJ, Zhao L, Dib MJ, Zhao M, Wang Z, Ebert C, Salman O, Azzo JD, Zamani P, van Empel V, Richards AM, Doughty R, Javaheri A, Mann DL, Rietzschell E, Kammerhoff K, Schafer P, Seiffert DA, Ramirez-Valle F, Cappola TP, Chirinos JA Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Adverse Outcomes in Heart Failure , Circ Heart Fail, 19: 2026,e012734


Vajargah KK, Dib MJ, Tavolinejad H, Zamani P, Richards AM, Mann DL, Rietzschel E, van Empel V, Burgess S, Cappola TP, Chirinos JA. Proteome-Wide Genetic Investigation of Kidney Function in Heart Failure With Preserved Ejection Fraction , JACC Heart Fail: 2025,102771


Saw EL, Werner LD, Cooper H, Pimental DR, Zamani P, Chirinos JA, Valero-Muñoz M, Sam F. Musclin Counteracts Skeletal Muscle Dysfunction and Exercise Intolerance in Heart Failure With Preserved Ejection Fraction , Circ Heart Fail, 18(6): 2025,e012350